• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同的炎症特征将 COVID-19 与流感区分开来,细胞因子风暴的贡献有限。

Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.

机构信息

Department of Emergency Medicine, Washington University School of Medicine, Saint Louis, MO, USA.

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

出版信息

Sci Adv. 2020 Dec 9;6(50). doi: 10.1126/sciadv.abe3024. Print 2020 Dec.

DOI:10.1126/sciadv.abe3024
PMID:33187979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7725462/
Abstract

We pursued a study of immune responses in coronavirus disease 2019 (COVID-19) and influenza patients. Compared to patients with influenza, patients with COVID-19 exhibited largely equivalent lymphocyte counts, fewer monocytes, and lower surface human leukocyte antigen (HLA)-class II expression on selected monocyte populations. Furthermore, decreased HLA-DR on intermediate monocytes predicted severe COVID-19 disease. In contrast to prevailing assumptions, very few (7 of 168) patients with COVID-19 exhibited cytokine profiles indicative of cytokine storm syndrome. After controlling for multiple factors including age and sample time point, patients with COVID-19 exhibited lower cytokine levels than patients with influenza. Up-regulation of IL-6, G-CSF, IL-1RA, and MCP1 predicted death in patients with COVID-19 but were not statistically higher than patients with influenza. Single-cell transcriptional profiling revealed profound suppression of interferon signaling among patients with COVID-19. When considered across the spectrum of peripheral immune profiles, patients with COVID-19 are less inflamed than patients with influenza.

摘要

我们研究了 2019 冠状病毒病(COVID-19)和流感患者的免疫反应。与流感患者相比,COVID-19 患者的淋巴细胞计数大致相当,单核细胞较少,选定的单核细胞群体表面人白细胞抗原(HLA)-II 类表达水平较低。此外,中间单核细胞 HLA-DR 的降低预示着 COVID-19 疾病的严重程度。与普遍的假设相反,只有少数(168 例中的 7 例)COVID-19 患者表现出细胞因子风暴综合征的细胞因子谱。在控制了年龄和样本时间点等多个因素后,COVID-19 患者的细胞因子水平低于流感患者。IL-6、G-CSF、IL-1RA 和 MCP1 的上调预示着 COVID-19 患者的死亡,但与流感患者相比并没有统计学上的更高。单细胞转录组谱分析显示 COVID-19 患者的干扰素信号受到严重抑制。从外周免疫谱的全谱来看,COVID-19 患者的炎症反应低于流感患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/10b2df367327/abe3024-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/aacc112519e4/abe3024-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/1c6c8db9592d/abe3024-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/8a9e6f0de202/abe3024-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/b8d318c690ba/abe3024-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/10b2df367327/abe3024-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/aacc112519e4/abe3024-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/1c6c8db9592d/abe3024-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/8a9e6f0de202/abe3024-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/b8d318c690ba/abe3024-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dbe/7725462/10b2df367327/abe3024-F5.jpg

相似文献

1
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.不同的炎症特征将 COVID-19 与流感区分开来,细胞因子风暴的贡献有限。
Sci Adv. 2020 Dec 9;6(50). doi: 10.1126/sciadv.abe3024. Print 2020 Dec.
2
Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease.在中重度疾病中,靶向免疫抑制可区分新冠病毒感染和流感。
medRxiv. 2020 May 30:2020.05.28.20115667. doi: 10.1101/2020.05.28.20115667.
3
Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection.血清蛋白质组学揭示了 COVID-19 感染早期炎症和免疫信号的全景。
Mol Cell Proteomics. 2020 Nov;19(11):1749-1759. doi: 10.1074/mcp.RP120.002128. Epub 2020 Aug 11.
4
SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.SARS-CoV-2 引起的细胞因子反应与其他严重感染患者中导致细胞因子风暴的呼吸道病毒不同。
Front Immunol. 2021 Mar 1;12:629193. doi: 10.3389/fimmu.2021.629193. eCollection 2021.
5
Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.通过I/III型干扰素的时间模式及流感对比揭示的新冠病毒感染中失调的抗病毒免疫
Nat Immunol. 2021 Jan;22(1):32-40. doi: 10.1038/s41590-020-00840-x. Epub 2020 Dec 4.
6
High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.高维单细胞分析揭示 COVID-19 的免疫特征。
Am J Physiol Lung Cell Mol Physiol. 2021 Jan 1;320(1):L84-L98. doi: 10.1152/ajplung.00355.2020. Epub 2020 Nov 4.
7
Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.流感感染、严重急性呼吸综合征、中东呼吸综合征和 COVID-19:细胞因子风暴——共同的特征和吸取的教训。
Clin Immunol. 2021 Feb;223:108652. doi: 10.1016/j.clim.2020.108652. Epub 2020 Dec 14.
8
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.COVID-19 相关细胞因子风暴综合征与诊断原则:一个古老而崭新的议题。
Emerg Microbes Infect. 2021 Dec;10(1):266-276. doi: 10.1080/22221751.2021.1884503.
9
Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.综合细胞因子和代谢物分析揭示 COVID-19 患者的免疫代谢重编程及其治疗意义。
Nat Commun. 2021 Mar 12;12(1):1618. doi: 10.1038/s41467-021-21907-9.
10
Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19.细胞因子风暴可能不是 COVID-19 恶化的主要原因。
Viral Immunol. 2021 Jun;34(5):336-341. doi: 10.1089/vim.2020.0243. Epub 2020 Nov 17.

引用本文的文献

1
Dynamics of Innate Immunity in SARS-CoV-2 Infections: Exploring the Impact of Natural Killer Cells, Inflammatory Responses, Viral Evasion Strategies, and Severity.新型冠状病毒感染中固有免疫的动力学:探究自然杀伤细胞、炎症反应、病毒逃避策略及疾病严重程度的影响
Cells. 2025 May 22;14(11):763. doi: 10.3390/cells14110763.
2
Interferon-β treatment reverses the detrimental effect of B-cell depletion therapy on respiratory virus infection.干扰素-β治疗可逆转B细胞清除疗法对呼吸道病毒感染的有害影响。
J Immunol. 2025 Jul 1;214(7):1688-1697. doi: 10.1093/jimmun/vkaf085.
3
Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection.

本文引用的文献

1
A dynamic COVID-19 immune signature includes associations with poor prognosis.一个动态的 COVID-19 免疫特征包括与预后不良的关联。
Nat Med. 2020 Oct;26(10):1623-1635. doi: 10.1038/s41591-020-1038-6. Epub 2020 Aug 17.
2
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.人类对轻度与重度 COVID-19 感染免疫的系统生物学评估。
Science. 2020 Sep 4;369(6508):1210-1220. doi: 10.1126/science.abc6261. Epub 2020 Aug 11.
3
Longitudinal analyses reveal immunological misfiring in severe COVID-19.
靶向CTP合成酶1以恢复干扰素诱导并阻碍新冠病毒感染中的核苷酸合成。
mBio. 2025 Apr 29:e0064925. doi: 10.1128/mbio.00649-25.
4
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.可溶性CD13是新型冠状病毒感染中中性粒细胞诱导的血栓形成性炎症的潜在介质。
JCI Insight. 2025 Apr 1;10(9). doi: 10.1172/jci.insight.184975. eCollection 2025 May 8.
5
Programmed cell death markers in COVID-19 survivors with and without sepsis.患有和未患有败血症的新冠康复者中的程序性细胞死亡标志物
Front Immunol. 2025 Feb 20;16:1535938. doi: 10.3389/fimmu.2025.1535938. eCollection 2025.
6
ZBP1-driven cell death in severe influenza.ZBP1驱动的严重流感中的细胞死亡。
Trends Microbiol. 2025 May;33(5):521-532. doi: 10.1016/j.tim.2024.12.008. Epub 2025 Jan 13.
7
TLR7 Promotes Acute Inflammatory-Driven Lung Dysfunction in Influenza-Infected Mice but Prevents Late Airway Hyperresponsiveness.Toll样受体7促进流感感染小鼠急性炎症驱动的肺功能障碍,但可预防后期气道高反应性。
Int J Mol Sci. 2024 Dec 21;25(24):13699. doi: 10.3390/ijms252413699.
8
Neurobiology of COVID-19-Associated Psychosis/Schizophrenia: Implication of Epidermal Growth Factor Receptor Signaling.新型冠状病毒肺炎相关精神病/精神分裂症的神经生物学:表皮生长因子受体信号传导的影响
Neuropsychopharmacol Rep. 2025 Mar;45(1):e12520. doi: 10.1002/npr2.12520.
9
Clustering based on renal and inflammatory admission parameters in critically ill patients admitted to the ICU.基于 ICU 收治危重症患者的肾脏和炎症入院参数的聚类分析。
PLoS One. 2024 Nov 1;19(11):e0307938. doi: 10.1371/journal.pone.0307938. eCollection 2024.
10
Complement activation and lung injury in Japanese patients with COVID-19: a prospective observational study.COVID-19 患者补体激活与肺损伤:一项前瞻性观察研究。
Sci Rep. 2024 Oct 22;14(1):24895. doi: 10.1038/s41598-024-76365-2.
纵向分析揭示了重症 COVID-19 中的免疫失调。
Nature. 2020 Aug;584(7821):463-469. doi: 10.1038/s41586-020-2588-y. Epub 2020 Jul 27.
4
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.深度免疫剖析 COVID-19 患者,揭示具有治疗意义的不同免疫类型。
Science. 2020 Sep 4;369(6508). doi: 10.1126/science.abc8511. Epub 2020 Jul 15.
5
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
6
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.COVID-19 和流感的免疫表型分析突出了 I 型干扰素在 COVID-19 重症发展中的作用。
Sci Immunol. 2020 Jul 10;5(49). doi: 10.1126/sciimmunol.abd1554.
7
Is a "Cytokine Storm" Relevant to COVID-19?“细胞因子风暴”与新冠病毒病有关吗?
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
8
Association between high serum total cortisol concentrations and mortality from COVID-19.血清总皮质醇浓度升高与新型冠状病毒肺炎(COVID-19)死亡率之间的关联。
Lancet Diabetes Endocrinol. 2020 Aug;8(8):659-660. doi: 10.1016/S2213-8587(20)30216-3. Epub 2020 Jun 18.
9
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.宿主对 SARS-CoV-2 的失衡反应导致 COVID-19 的发生。
Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.
10
Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.严重急性流感感染的第一周期间细胞免疫应答受损。
J Infect Dis. 2020 Sep 1;222(7):1235-1244. doi: 10.1093/infdis/jiaa226.